India’s policies on access to life-saving medications under Ayushman Bharat are half-measures at best, and the poor attention to this crucial aspect of healthcare has come under the spotlight after the Supreme Court took up the matter suo motu. A woman waiting for a decision by the Kerala High Court to access a costly breast cancer drug ultimately passed away while the case remained undecided after being listed 57 times; no hearing was fixed after 2023. The neglected issue of access to life-saving drugs has now been taken up by the apex court, while the Kerala HC is also suo motu considering the exorbitant pricing of life-saving patented drugs. The tragedy of people dying in India without access to affordable and........

© Free Press Journal